Conference Coverage

VIDEO: CDC urges flu shots for all eligible patients


 

AT A CDC/NFID PRESS CONFERENCE

References

WASHINGTON – While influenza vaccination rates have increased in recent years, work still needs to be done to achieve the Centers for Disease Control and Prevention’s goal of at least 70% vaccination.

“Vaccination is the single-most-important step people can take to protect themselves from influenza,” Dr. Tom Frieden, CDC director said at a press conference called by his agency and the National Foundation for Infectious Diseases (NFID). He urged people to get their influenza vaccination and make sure their children do as well.

The CDC estimates that 47% of U.S. residents aged 6 months or older received an influenza vaccination in the last flu season. The only age group that meets the federal 70% benchmark is the 6-23 months age group, with about 75% coverage. Children aged 2-4 years have a vaccination rate of 68%; adults aged 65 years and older have a vaccination rate of 67%; and 62% of children aged 5-12 years get vaccinated. The lowest vaccination rate is among adults aged 18-49 years, of whom only 40% get vaccinated.

Dr. Frieden was joined at the press event by Dr. William Schaffner, NFID medical director; Dr. Wendy Sue Swanson of Seattle Children’s Hospital; and Dr. Kathleen Neuzil, director of the Center for Vaccine Development at the University of Maryland, Baltimore.

In this interview, Dr. Neuzil discusses which strains of influenza are expected to be dominant in the coming flu season, whether to expect a strain mutation similar to what happened last season, the importance of getting children vaccinated, and pneumococcal vaccination for children and older adults.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

dchitnis@frontlinemedcom.com

Recommended Reading

New 9-valent HPV vaccine shown to be as effective as quadrivalent vaccine
MDedge Dermatology
ACIP recommends meningococcal B vaccine during college outbreaks
MDedge Dermatology
ACIP votes on incorporating 9-valent HPV vaccine into recommendations
MDedge Dermatology
Racial disparities in HPV vaccine recommendations persist
MDedge Dermatology
New 9-valent HPV vaccine is efficacious, well tolerated
MDedge Dermatology
Gardasil vaccination reduces cervical dysplasia in teen years
MDedge Dermatology
Single HPV vaccine dose appears as effective as full course
MDedge Dermatology
ACOG adds HPV-9 to vaccination advice
MDedge Dermatology
9-valent HPV vaccine equally effective in adolescents, young women
MDedge Dermatology
HPV vaccine coverage continues to lag
MDedge Dermatology